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Abstract
Background: Human herpes virus 8 (HHV-8) is the etiologic agent associated with development of classical, AIDS-
related, iatrogenic, and endemic Kaposi’s sarcoma (KS). Several studies provide strong evidence that HHV-8 can be
transmitted by blood transfusion. We evaluated the seroprevalence and potential risk factors of HHV-8 infection in
blood donors in one region. We surveyed HHV-8 infection among 4461 blood donors in Xinjiang, China, a unique
endemic area for HHV-8 and KS.
Results: The HHV-8 seroprevalence was higher in local minority groups which comprise most KS cases in China,
than in Han people. HHV-8 prevalence was 18.6% in the Han ethnic group, 25.9% in Uygur subjects, 29.2% in Kazak
subjects, 36.8% in Mongolian subjects, and 21.9% in other ethnic groups. In several subgroups, the time of
donation of whole blood seemed to be a risk factor. In HHV-8-seropositive subjects, a larger fraction of local
minorities (23.9%) had high HHV-8 titers than that of Han subjects (9.2%). HHV-8 infection was associated with
ethnicity and residence.
Conclusion: HHV-8 seroprevalence was significantly high among blood donors in Xinjiang, where the prevalence
of KS correlates with HHV-8 prevalence and titers in Uygur and Kazak ethnic groups. Blood exposure represented
by the frequency of blood donation indicated a possible blood-borne transmission route of HHV-8 in Xinjiang.
Detecting anti-HHV-8 antibodies before donation in this region is therefore important.
Background
Human herpes virus 8 (HHV-8) is the etiologic agent
associated with the development of classical, AIDS-
related, iatrogenic, and endemic Kaposi’s sarcoma (KS)
[1,2]. HHV-8 is also associated with lymphoproliferative
diseases, including primary effusion lymphomas and
multicentric Castleman’s disease [3,4]. Emerging evi-
dence suggests that HHV-8 may be transmitted through
sexual contact [5,6], saliva [7], and blood transfusion
[8-10]. In the USA, where HHV-8 seroprevalence is low
(<10%), HHV-8 is spread by the sexual route, at least
among homosexual men [5,6]. In regions or countries
with high HHV-8 seroprevalence (>25%), HHV-8 infec-
tion increases throughout childhood, suggesting that
transmission occurs through saliva or other horizontal
routes [11-13]. Of note, HHV-8 infection has been
observed in patients who received non-leukocyte-
reduced blood [8]. Infectious viruses or viral DNA have
been identified from blood donors in the USA and
Africa [14,15]. HHV-8 infection has been observed in
patients receiving blood transfusions in Uganda, thereby
indicating blood-borne transmission of HHV-8 [9,10].
HHV-8 seroprevalence among blood donors varies
between different regions. HHV-8 prevalence ranges
from 0.2% in Japan, 0-15% in the USA and the UK, up
to >50% in some African countries [16,17]. There is a
wide range of variations in HHV-8 infection in South
America [18]. A few studies focusing on small study
populations have been carried out in China. In the
inland areas of China, HHV-8 seroprevalence in general
population was <8% [19,20]. In Xinjiang, in the north-
west of China, HHV-8 seroprevalence ranged from
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[21-24]. The mode of HHV-8 transmission remains
undefined, but the unique pattern of HHV-8 infection
in this geographic region correlated well with an
increased incidence of KS [21,22,24].
Results
Demographic patterns of HHV-8 seroprevalence among
blood donors
A total of 4461 serum samples from blood donors were
analyzed. Demographic patterns and blood donation-
associated behavioral characteristics of HHV-8 infection
are shown in Tables 1 and 2, respectively. Overall, 3551
subjects were HHV-8-negative (79.6%) whereas 910 par-
ticipants were HHV-8-positive (20.4%). In this popula-
tion, there was no significant difference in HHV-8
seroprevalence with respect to sex, age, marriage, occu-
pation, education, blood type, and times of donation of
blood components. Xinjiang residents exhibited HHV-8
seroprevalence of 21.3%, whereas the value for non-resi-
dents was 17.7%. The latter were all of Han extraction
who had migrated to Xinjiang from inland areas. There
was a difference among ethnic groups. HHV-8 seropre-
valence in the Han population was lower (18.6%) than
Table 1 Sociodemographic characteristics by HHV-8 seroprevalence
Characteristics Number of subjects (%) HHV-8 sero-positivity (%) OR (95% CI) p
Sex 1.1 (0.9-1.2) 0.448
Male 2662 (59.7) 533 (20.0)
Female 1799 (40.3) 377 (21.0)
Ethnic background 0.000*
Han 3386 (75.9) 629 (18.6)
Uygur 526 (11.8) 136 (25.9) 1.5 (1.2-1.9) 0.000*
Kazak 161 (3.6) 47 (29.2) 1.8 (1.3-2.6) 0.001*
Mongolian 87 (2.0) 32 (36.8) 1.0 (1.6-4.0) 0.000*
Other 301 (6.7) 66 (21.9) 2.6 (0.9-1.6) 0.155
Age group (years) 0.777
19-24 2076 (46.5) 430 (20.7)
24-29 904 (20.3) 166 (18.4) 0.9 (0.7-1.1) 0.141
29-34 590 (13.2) 120 (20.3) 1.0 (0.8-1.2) 0.843
34-39 489 (11.0) 102 (20.9) 1.0 (0.8-1.3) 0.843
39-44 245 (5.5) 56 (22.9) 1.1 (0.8-1.6) 0.436
44-49 105 (2.4) 24 (22.9) 1.1 (0.7-1.8) 0.598
49-54 43 (1.1) 10 (23.3) 1.2 (0.6-2.4) 0.684
>54 9 (0.2) 2 (22.2) 1.1 (0.2-5.3) 0.911
Martial status 1.1 (0.9-1.3) 0.301
Unmarried 3078 (69.0) 615 (20.0)
Ever married 1383 (31.0) 295 (21.3)
Occupation 0.208
Soldier 157 (3.5) 25 (15.9)
Student 1290 (28.9) 276 (21.4) 1.4 (0.9-2.2) 0.112
Professional specialty 740 (16.6) 159 (21.5) 1.4 (0.9-2.3) 0.118
Business\service 697 (15.6) 125 (17.9) 1.0 (0.7-1.8) 0.550
Unidentified job 1577 (35.4) 325 (20.6) 1.3 (0.9-2.1) 0.165
Educational level 0.245
College 1034 (23.2) 217 (21.0)
Junior College 1080 (24.2) 237 (21.9) 1.0 (0.9-1.3) 0.592
Technical Secondary School 459 (10.3) 79 (17.2) 0.8 (0.6-1.0) 0.092
Senior High School 935 (21.0) 197 (21.1) 1.0 (0.9-1.2) 0.964
Junior High School 844 (18.9) 162 (19.2) 0.9 (0.7-1.1) 0.336
Elementary School 109 (2.4) 18 (16.5) 0.3 (0.3-0.9) 0.273
Residence 1.3 (1.1-1.5) 0.009*
Xinjiang 3321 (74.4) 708 (21.3)
Outside of Xinjiang 1140 (25.6) 202 (17.7)
Total 4461 (100.0) 910 (20.4)
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(29.2%), Mongolian (36.8%) and others (21.9%). HHV-8
seroprevalence tended to increase among local minority
groups. Most individuals were blood donors, who were
negative for hepatitis-B virus (HBV), hepatitis-C virus
(HCV), human immunodeficiency virus (HIV), and
syphilis (99.8%). Among seven positive subjects for these
pathogens, three were HHV-8-positive individuals
(42.9%). The relevance of HBV, HCV, HIV, and syphilis
to HHV-8 seroprevalence was not further analyzed
because the small sample size.
Assessment of risk factors
The univariate associations between HHV-8 seroprave-
lence and subject characteristics are illustrated in Tables
1 and 2. Ethnic background was found to be associated
with HHV-8-positive status. This variable exhibited a
statistically significant difference whereby the odds ratio
(OR) was high for Uygur (1.5, 95% confidence interval
(CI) 1.2-1.9, p < 0.000) and Kazak (1.8, 95% CI 1.3-2.6,
p < 0.001) ethnic groups. Residence appeared to be
associated with HHV-8 infection (OR = 1.3, 95% CI 1.1-
1.5, p < 0.009). No associations were observed between
HHV-8 seroprevalence and sex, age, education, marital
status, occupation and blood donation-associated
behaviors. To further identify independent risk factors,
all variables from the univariate analysis were entered
into multiple logistic regression models (Table 3). In
this analysis, HHV-8-positive status was associated with
Uygur (OR = 1.4, 95% CI 1.1-1.9, p < 0.000) and Kazak
(OR = 1.8, 95% CI 1.2-2.6, p < 0.000) ethnic groups.
Table 2 HHV-8 seroprevalence by blood donor-associated behaviors
Characteristics Number of subjects (%) HHV-8 sero-positivity (%) OR (95% CI) p
Type of blood donation 1.0(0.7-1.4) 0.962
Whole blood 4232 (94.9) 863 (20.4)
Blood component 229 (5.1) 47 (20.5)
Time of donation of whole blood 0.845
1 2702(63.8) 557 (20.6)
2 851 (20.1) 176 (20.7) 1.0 (0.7-1.4) 0.958
3 352 (8.3) 76 (21.6) 0.0 (0.7-1.4) 0.758
4 168 (4.0) 25 (14.9) 1.1 (0.7-1.6) 0.151
5 67 (1.6) 13 (19.4) 0.7 (0.4-1.2) 0.841
6 39 (0.9) 7 (17.9) 0.9 (0.5-1.9) 0.711
7 25 (0.6) 4 (16.0) 0.8 (0.4-2.0) 0.593
8 28 (0.7) 5 (17.9) 0.7 (0.2-2.3) 0.740
Time of donation of blood components 0.678
1-5 64 (27.9) 13 (20.3)
6-10 29 (12.7) 10 (34.5) 1.0 (0.5-1.8) 0.067
12-15 33 (14.4) 6 (18.2) 2.1 (1.0-4.4) 0.987
16-20 24 (10.5) 4 (16.7) 0.9 (0.4-2.1) 0.754
21-25 19 (8.3) 2 (10.5) 0.8 (0.3-2.3) 0.652
26-30 26 (11.4) 5 (19.2) 0.5 (0.1-2.0) 0.299
31-40 20 (8.7) 3 (15.0) 0.9 (0.7-2.5) 0.884
41-44 14 (6.1) 4 (28.6) 0.7 (0.2-2.4) 0.553
Pathogens screen 0.0 (0.0-1.0) 0.982
Seronegative 4452 (99.8) 907 (20.4) 2.9(0.7-13.1) 0.159
Seropositive 7 (0.2) 3 (42.9)
(HBV/HCV/HIV/syphilis)
Table 3 Analyses by risk factor
OR (95% CI) p
Ethnic background 0.000*
Han 1.0
Uygur 1.4 (1.1-1.9) 0.004*
Kazak 1.8 (1.2-2.6) 0.004*
Mongolian 2.7 (1.7-4.2) 0.000*
Other 1.3 (0.9-1.7) 0.142
Time of donation of whole blood 0.185
1 1.0
2 1.2 (0.9-1.7) 0.291
3 1.9 (1.1-3.2) 0.021*
4 1.5 (0.7-3.0) 0.278
5 3.5 (1.3-9.7) 0.016*
6 4.6 (1.2-17.8) 0.025*
7 4.1 (0.8-20.7) 0.089
8 5.1 (1.1-23.9) 0.040*
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the Mongolian (OR = 2.7, 95% CI 1.7-4.2, p < 0.000)
ethnic group. With the increasing frequency of donation
of whole blood, the possibility of infection also increased
in several subgroups such as 3 (OR = 1.9, 95% CI 1.1-
3.2, p < 0.021), 5 (OR = 3.5, 95% CI 1.3-9.7, p < 0.016),
6 (OR = 4.6, 95% CI 1.2-17.8, p < 0.025), and 8 (OR =
5.1, 95% CI 1.1-23.9, p < 0.04). There was no association
between HHV-8 seroprevalence and the other variables
evaluated in Tables 1 and 2 (data not shown).
HHV-8 antibody titers in HHV-8-positive individuals
We compared relative levels of HHV-8 antibody titers
among HHV-8-positive subjects. High titers were noted
in: 12.2% of those aged <30 years, 13.4% of subjects
aged >30 years, 12% of unmarried individuals, and
13.9% of married individuals (Figure 1). There was no
major difference in these subgroups. Among study sub-
jects, 11.9% of individuals who had a Junior High
School-education had high titers. This number increased
to 15.6% for those who studied beyond Junior High
School. Only 9.2% of HHV-8-positive subjects from the
Han ethnic group had high titers. This number
increased to 23.9% in minority groups which included
the Uygur and Kazak ethnic groups. As compared with
subjects from the Han ethnic group, local minorities
had a larger proportion of individuals with a higher
level of HHV-8 antibody titers.
We further examined HHV-8 antibody titers in each
individual ethnic group. The Han group exhibited a
HHV-8 seroprevalence of 18.6%, but only 9.2% of HHV-
8-positive subjects had high anti-HHV-8 titers (Figure
2). A similar trend was seen in the Mongolian group
and other groups except the Uygur and Kazak groups.
The Mongolian group showed a HHV-8 seroprevalence
of 36.8%, whereas 18.8% had high HHV-8 antibody
titers. Other groups showed a HHV-8 seroprevalence of
21.9%, whereas 12.1% had high HHV-8 titers. Strikingly,
different results were seen in Uygur and Kazak groups;
24.3% of the Uygur group with HHV-8 infection had
high HHV-8 titers, and 23.4% of Kazak who were HHV-
8 positive had high HHV-8 titers. Therefore, a larger
fraction of Uygur and Kazak groups had higher HHV-8
antibody titers than those in the other ethnic groups.
Discussion
The present study was the first large-scale survey of
HHV-8 seroprevalence in blood donors in China. Recent
reports showed that HHV-8 seroprevalence was 7.3% in
Liaonin province and 5.7% in Shandong province among
healthy blood donors [19,25]. These studies focused on
the Han ethnic group, and the study population was
small. A study in the Han ethnic group in Hubei pro-
vince revealed that HHV-8 seroprevalence was 5.2%
[20]. The prevalence of HHV-8 infection reported in
these studies was similar to those among the adult
population in North America [6,14,26]. These observa-
tions suggest that HHV-8 seroprevalence in China was,
in general, low. The Xinjiang area, located in the north-
west of China, exhibited a distinct pattern. We noted
that HHV-8 seroprevalence was relatively high in the
Han ethnic group living in Xinjiang: 18.6% of blood
donors were HHV-8 positive. Moreover, HHV-8 sero-
prevalence was 17.7% among the 1140 non-residential
Han ethnic group who migrated to Xinjiang from inland
areas. Thus, an elevated HHV-8 seroprevalence in the
Han ethnic group in Xinjiang province implies an asso-
ciation of HHV-8 infection with the living environment.
These potential factors which contribute to the differ-
ences within the same ethnic group suggest an increased
Figure 1 Relative HHV-8 high titers in different subgroups among blood donors.
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have close contact with highly infected populations. And
the relatively low level of public health in Xinjiang pro-
vince due to the economic situation in this region may
benefit the spread or transmission of HHV-8, but this
hypothesis needs conformation. The precise impact of
being resident in Xinjiang on HHV-8 infection could
not be ascertained because of the cross-sectional nature
of the present study.
The present study suggested that HHV-8 seropreva-
lence was associated with ethnicity but not with sex,
age, marital status, occupation, educational level, blood
type, and time of donation of blood components.
Among blood donors, HHV-8 seroprevalence was 18.6%
in the Han group, 25.9% in the Uygur group, 29.2% in
the Kazak group, and 36.8% in the Mongolian group.
When combined, the mean prevalence of HHV-8 infec-
tion in local minorities was 30.6%. Compared with Han
subjects living in Xinjiang, the elevated HHV-8 seropre-
valence in local minorities was significant. Hence, what
w a st h eb a s i sf o rt h eo b s e r v e dd i f f e r e n c e s ?I ti sk n o w n
that local minorities have resided in Xinjiang for genera-
t i o n s ,a n dt h a tt h e yh a v eu n i q u ec u l t u r a lp r a c t i c e s .A n
intriguing possibility is that different cultural practices
or social behaviors may play a part in HHV-8 infection.
Alternatively, genetic factors may affect the susceptibility
to HHV-8 infection. Additional studies are required to
address these issues.
Several studies have demonstrated that HHV-8 sero-
prevalence is correlated with the occurrence of KS in
Europe and Africa [27-30]. In Ghana and Egypt, a high
prevalence of HHV-8 does not correlate well with KS
onset [11,31]. HHV-8 seroprevalence is high among
Amerindians in Brazil, French Guiana and Ecuador
[32-34]. Nonetheless, KS has not been reported for
these populations. The present study revealed that
HHV-8 seroprevalence was higher in Han subjects resid-
i n gi nX i n j i a n gt h a ni nt h ei n l a n da r e a so fC h i n a .
Furthermore, it was higher in local minority groups
than in Han subjects. HHV-8 prevalence remained high
in blood donors residing in Xinjiang, but classical KS
and AIDS-related KS were observed only among local
minority groups [21,22]. Taken together, these data sup-
port the hypothesis that additional factors other than
HHV-8 may be involved in KS development.
Several researchers reported blood-borne transmission
of HHV-8 among a large cohort of drug users, or pro-
spective studies on blood-transfusion recipients [8,10].
T h ep r e s e n ts t u d yw a si na c c o r d a n c ew i t ht h e s es t u d i e s
because it established a positive relationship between an
increasing prevalence of infection with the correspond-
ing frequency of donation of whole blood. To a certain
extent, the time of donation represents the opportunity
of blood exposure. In China, laws pertaining to donation
of whole blood were passed in 1992. Before 1992, non-
standard protocols for blood collection, and absence of
instruments and materials were common. These condi-
tions could increase the prevalence of HHV-8 infection
by blood exposure. A possible explanation for the con-
tradictory results in the univariate analysis with respect
to the time of donation of blood components may be
due to the small number of samples in each group or
undetermined factors.
T h e r ew a sad i f f e r e n c ei nH H V - 8a n t i b o d yt i t e r s
among HHV-8-seropositive individuals in the present
study. Specifically, a larger fraction of local minorities
Figure 2 HHV-8 infection by seroprevalence and high antibody titers in different ethnic groups
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was evident in the Uygur and Kazak ethnic groups.
Whether this reflects enhanced replication of HHV-8 or
enhanced immune responses is not clear. Notably, KS
patients are seen in Uygur and Kazak ethnic groups in
Xinjiang hospitals [21,22]. The patients are typically
elderly men who have multiple nodular lesions in the
l o w e ro ru p p e re x t r e m i t i e s .I n t r i g u i n g l y ,K Sp a t i e n t s
tend to be younger among those who are also infected
with HIV. Hence, high HHV-8 antibody titers in Uygur
and Kazak groups appeared to correlate with the devel-
opment of KS in these ethnic groups.
Conclusions
HHV-8 seroprevalence was significantly high in blood
donors from Xinjiang. A critical question relevant to
public health is if HHV-8 is transmitted through blood
transfusion in the Xinjiang area. Several studies in the
USA and Africa suggest an association between HH-8
infection with blood transfusion Error! Reference source
not found. Given that HHV-8 seroprevalence in the Xin-
jiang area is high, assessing the risk of HHV-8 transmis-
sion via blood transfusion in future studies is essential.
Methods
Ethical approval of the study protocol
The present study was approved by the Institutional
Ethics Committee of the First Teaching Hospital of Xin-
jiang Medical University (Urumqi, Xinjiang, China).
Written informed consent was obtained from all sub-
jects, and patient confidentiality was ensured.
Study population
A cross-sectional study was designed to assess the sero-
prevalence of HHV-8 infection among blood donors in
Xinjiang, China. Serum samples, collected and deposited
from all five blood banks belonging to Xinjiang Blood
Center between August 2006 and May 2007, were ana-
lyzed. These samples were derived from 4832 blood
donors belonging to different ethnic groups: Han,
Uygur, Kazak, Mongolian, and others. All samples went
through a standard screening for HBV, HCV, HIV, and
syphilis. A questionnaire regarding age, sex, ethnicity,
marital status, education and residence was collected. Of
4832 blood donors, 4461 blood donors completed all
sections of the questionnaire. Serum samples were cen-
trifuged and stored at -80°C before HHV-8 serologic
testing.
Laboratory procedures
The coded serum specimens were tested for HHV-8 anti-
gens of ORF73,O R F 65 and K8.1 using enzyme-linked
immunosorbent assays as described
22,24 Error! Reference
source not found. This assay has a sensitivity of 82% and
a specificity of 96%
22 . Briefly, viral antigen-coated plates
were incubated with serum samples diluted at 1:100. This
was followed by incubation with goat anti-human immu-
noglobulins (including IgG) conjugated with horseradish
peroxidase (HRP; Tago Immunologicals). The mean opti-
cal density at 450 nm was determined. Controls included
serum samples derived from KS patients and HHV-8-
negative individuals. Based on the assays from control
groups, the HHV-8-positive cutoff was set to the value
that was three-times that of the negative control. The
HHV-8 high titer was set to the value that was more than
five-times that of the negative control.
Statistical analyses
All statistical analyses were carried out using SPSS soft-
ware version 12.0 (SPSS Incorporated, Chicago, IL, USA).
The univariate analysis of categorical variables was evalu-
ated by #2 test with P < 0.05 being considered significant.
Associations revealed by OR and P were evaluated at a
CI of 95%. Multivariate logistic regression analysis was
carried out to control for confounding factors. CI was
calculated based on coefficients and standard errors from
t h el o g i s t i cm o d e l .S e r o p o s i t i v ep r e v a l e n c ea n dr i s kf a c -
tors were compared between groups.
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